These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1910928)

  • 1. [Clinical diagnosis of Duchenne muscular dystrophy using anti-dystrophin antibodies].
    Arahata K
    No To Shinkei; 1991 May; 43(5):411-9. PubMed ID: 1910928
    [No Abstract]   [Full Text] [Related]  

  • 2. ELISA quantitation of dystrophin for the diagnosis of Duchenne and Becker muscular dystrophies.
    Byers TJ; Neumann PE; Beggs AH; Kunkel LM
    Neurology; 1992 Mar; 42(3 Pt 1):570-6. PubMed ID: 1549217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies.
    Matsumura K; Campbell KP
    Muscle Nerve; 1994 Jan; 17(1):2-15. PubMed ID: 8264699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of genetic deletions in Becker muscular dystrophy using monoclonal antibodies against a deletion-prone region of dystrophin.
    Le Thiet Thanh ; Nguyen Thi Man ; Hori S; Sewry CA; Dubowitz V; Morris GE
    Am J Med Genet; 1995 Aug; 58(2):177-86. PubMed ID: 8533812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetic counselling for Duchenne muscular dystrophy].
    Ousawa M; Saito K; Ikeya K; Fukuyama Y
    No To Shinkei; 1991 May; 43(5):429-41. PubMed ID: 1910929
    [No Abstract]   [Full Text] [Related]  

  • 6. The concomitant use of dystrophin and utrophin/dystrophin related protein antibodies to reduce misdiagnosis of Duchenne/Becker muscular dystrophy.
    Khurana TS; Specht LA; Beggs AH; Tomé FM; Letureq F; Chevallay M; Chafey P; Kunkel LM
    Biochem Biophys Res Commun; 1997 Dec; 241(2):232-5. PubMed ID: 9425255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and carrier detection in a Duchenne muscular dystrophy family by multiplex polymerase chain reaction and microsatellite analysis.
    Jongpiputvanich S; Norapucsunton T; Mutirangura A
    J Med Assoc Thai; 1996 Dec; 79 Suppl 1():S15-21. PubMed ID: 9071063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [[Study of dystrophin in muscular dystrophy--why and when?].
    Sariola H; Koistinen H; Wallgren-Pettersson C; Rapola J
    Duodecim; 1992; 108(6):591-6. PubMed ID: 1366119
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection of gene deletions by PCR analysis in a Malaysian patient with Duchenne muscular dystrophy.
    Lee MK; Manonmani V; Arahata K
    Med J Malaysia; 1993 Mar; 48(1):46-50. PubMed ID: 8341171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular diagnosis of Duchenne muscular dystrophy by use of a conformational polymorphism in the absence of DNA from an affected boy.
    Tuffery S; Moine P; Sarda P; Lefort G; Boulot P; Demaille J; Claustres M
    Genet Couns; 1994; 5(2):183-5. PubMed ID: 7917130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [DNA diagnosis of Duchenne muscular dystrophy].
    Matsumoto T
    No To Shinkei; 1991 May; 43(5):421-8. PubMed ID: 1680358
    [No Abstract]   [Full Text] [Related]  

  • 12. Relatively low proportion of dystrophin gene deletions in Israeli Duchenne and Becker muscular dystrophy patients.
    Shomrat R; Gluck E; Legum C; Shiloh Y
    Am J Med Genet; 1994 Feb; 49(4):369-73. PubMed ID: 8160727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy.
    Araki E; Nakamura K; Nakao K; Kameya S; Kobayashi O; Nonaka I; Kobayashi T; Katsuki M
    Biochem Biophys Res Commun; 1997 Sep; 238(2):492-7. PubMed ID: 9299538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic counseling of isolated carriers of Duchenne muscular dystrophy.
    Hoffman EP; Pegoraro E; Scacheri P; Burns RG; Taber JW; Weiss L; Spiro A; Blattner P
    Am J Med Genet; 1996 Jun; 63(4):573-80. PubMed ID: 8826437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heteroduplex analysis of the dystrophin gene: application to point mutation and carrier detection.
    Prior TW; Papp AC; Snyder PJ; Sedra MS; Western LM; Bartolo C; Moxley RT; Mendell JR
    Am J Med Genet; 1994 Mar; 50(1):68-73. PubMed ID: 8160755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Microsatellite analysis of Duchenne muscular dystrophy].
    Fujishita S; Shibuya N
    Nihon Rinsho; 1997 Dec; 55(12):3131-6. PubMed ID: 9436423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Specificity of the dystrophin immunohistochemical technique in muscular dystrophy].
    Colomer Oferil J; Vila Torres J; Huezo Montoya C
    Neurologia; 1993 May; 8(5):112-5. PubMed ID: 8507503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dystrophin and dystrophin-associated proteins. Their evaluation at the neuromuscular pathology laboratory].
    Navarro C
    Rev Neurol; 1999 Jan 16-31; 28(2):154-8. PubMed ID: 10101784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duchenne muscular dystrophy: the gene and the protein.
    Love DR; Davies KE
    Mol Biol Med; 1989 Feb; 6(1):7-17. PubMed ID: 2666821
    [No Abstract]   [Full Text] [Related]  

  • 20. Can a newer MR contrast agent be used to monitor disease progression in muscular dystrophy?
    Unger EC
    Radiology; 2009 Jan; 250(1):1-3. PubMed ID: 19092081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.